Chimera Therapeutics
Chimera Therapeutics improves the effectiveness of drugs targeted at deadly cancers while virtually eliminating the harmful side effects of conventional treatments. Our technology exclusively targets diseased cells, leaving healthy ones unharmed.
| Startup type: | Competition Entry |
| Status: | Dead |
| Stage: | Just An Idea |
| Publicity: | Stealth mode. No media please. |
OUR NEWS
Chimera Therapeutics has no news yet.
THINGS WE NEED
The Chimera Therapeutics team hasn't posted any needs yet.
COMMENTS (0)
Followers (3)
View all-
Jeff McLean
Business Management graduate from University of Maryland. Currently working as Executive Vice President of Global Commercial Strategy at Cooper Companies Incorporated.
-
Radostina Ruseva
Business development consultant, MBA at TUM Business School, Computer Science, Multimedia and Communications at LMU Munich and University of Helsinki, lecturer at Sofia University, employee of Microsoft, Siemens, BMW, Telefonica, start-ups co-founder
-
Michael Friis
Msc. in Computer Science from University of Copenhagen incl. studies at Caltech. Experience with facebook development.